What does PHARMACIE DEBIEVE SYLVIE do?

PHARMACIE DEBIEVE SYLVIE is a pharmacy in Honnelles. Private Limited, started on 28 January 2014, 1 establishment.

What is the address of PHARMACIE DEBIEVE SYLVIE?

The registered office of PHARMACIE DEBIEVE SYLVIE is located at Rue Charles Bernier(A) 59, 7387 Honnelles.

Is PHARMACIE DEBIEVE SYLVIE still active?

Yes. According to the CBE (20 September 2026) PHARMACIE DEBIEVE SYLVIE is active, legal situation “Normale toestand”, started on 28 January 2014.

Is PHARMACIE DEBIEVE SYLVIE registered on Peppol?

Yes, PHARMACIE DEBIEVE SYLVIE is registered on the Peppol network with ID 0208:0544811683.

What is the enterprise number of PHARMACIE DEBIEVE SYLVIE?

The enterprise number of PHARMACIE DEBIEVE SYLVIE is BE0544811683.

When was PHARMACIE DEBIEVE SYLVIE founded?

PHARMACIE DEBIEVE SYLVIE was founded on 28 January 2014.

Who are the directors of PHARMACIE DEBIEVE SYLVIE?

According to the 2025 annual accounts, the directors of PHARMACIE DEBIEVE SYLVIE are: SYLVIE DEBIEVE.

Is PHARMACIE DEBIEVE SYLVIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 January 2014; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE DEBIEVE SYLVIE make in 2025?

PHARMACIE DEBIEVE SYLVIE posted a profit after taxes of € 29,087 in financial year 2025.

What is the revenue of PHARMACIE DEBIEVE SYLVIE?

As a small company, PHARMACIE DEBIEVE SYLVIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 81,386.

PHARMACIE DEBIEVE SYLVIE (Private Limited) - Honnelles

Dossier PHARMACIE DEBIEVE SYLVIE, printed on 20 September 2026 from databakkes.be/en/0544811683/pharmacie-debieve-sylvie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DEBIEVE SYLVIE from Honnelles, company number BE0544811683, closed financial year 2025 with a result of € 29,087 after tax. For that financial year PHARMACIE DEBIEVE SYLVIE recorded a gross margin of € 81,386 and equity of € 125,242. Compared with financial year 2024, the result moved from € 17,868 to € 29,087. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.

What it is worth Growing

€ 125,242

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 29,087

▲ 63% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 82,319

▲ 46% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 20,000 paid out

69 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost estimate Staff cost at a one-person company Staff Only people on the payroll count here.€ 2,999 Likely the director’s social contribution or pension premium.The director’s pay Already netted into the gross margin, not shown separately in the accounts. Typical for one-person companies € 45,000 gross per year minimum for the reduced tax rate≈ € 2,100 net per month after contributions, tax and usually some benefits in kind, roughly Assumption based on the chart of accounts, not a figure from the source.

€ 2,999

▼ 94% vs 2024

No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 49,799

▼ 31% vs 2024

€ 17,901 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 39,429

▼ 6% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 3,234

▼ 72% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 111,401 Gross margin 2022: € 111,401 First fiscal year in the series	€ 110,344 Gross margin 2023: € 110,344 ▼ 1% vs 2022 (€ 111,401) Unfavourable step	€ 109,633 Gross margin 2024: € 109,633 ▼ 1% vs 2023 (€ 110,344) Unfavourable step	€ 81,386 Gross margin 2025: € 81,386 ▼ 26% vs 2024 (€ 109,633) Unfavourable step	▼ 26%
Profit after taxes	€ 31,182 Profit after taxes 2022: € 31,182 First fiscal year in the series	€ 28,519 Profit after taxes 2023: € 28,519 ▼ 9% vs 2022 (€ 31,182) Unfavourable step	€ 17,868 Profit after taxes 2024: € 17,868 ▼ 37% vs 2023 (€ 28,519) Unfavourable step	€ 29,087 Profit after taxes 2025: € 29,087 ▲ 63% vs 2024 (€ 17,868) Favourable step	▲ 63%
Equity	€ 124,767 Equity 2022: € 124,767 First fiscal year in the series	€ 118,286 Equity 2023: € 118,286 ▼ 5% vs 2022 (€ 124,767) Unfavourable step	€ 116,154 Equity 2024: € 116,154 ▼ 2% vs 2023 (€ 118,286) Unfavourable step	€ 125,242 Equity 2025: € 125,242 ▲ 8% vs 2024 (€ 116,154) Favourable step	▲ 8%
Total debts	€ 258,942 Total debts 2022: € 258,942 First fiscal year in the series	€ 236,823 Total debts 2023: € 236,823 ▼ 9% vs 2022 (€ 258,942) Favourable step	€ 187,306 Total debts 2024: € 187,306 ▼ 21% vs 2023 (€ 236,823) Favourable step	€ 148,558 Total debts 2025: € 148,558 ▼ 21% vs 2024 (€ 187,306) Favourable step	▼ 21%
Cash	€ 82,450 Cash 2022: € 82,450 First fiscal year in the series	€ 80,106 Cash 2023: € 80,106 ▼ 3% vs 2022 (€ 82,450) Unfavourable step	€ 56,206 Cash 2024: € 56,206 ▼ 30% vs 2023 (€ 80,106) Unfavourable step	€ 82,319 Cash 2025: € 82,319 ▲ 46% vs 2024 (€ 56,206) Favourable step	▲ 46%
Land & buildings	€ 74,800 Land & buildings 2022: € 74,800 First fiscal year in the series	€ 68,000 Land & buildings 2023: € 68,000 ▼ 9% vs 2022 (€ 74,800) Unchanged	€ 61,200 Land & buildings 2024: € 61,200 ▼ 10% vs 2023 (€ 68,000) Unchanged	€ 54,400 Land & buildings 2025: € 54,400 ▼ 11% vs 2024 (€ 61,200) Unchanged	▼ 11%
Retained profit	€ 16,167 Retained profit 2022: € 16,167 First fiscal year in the series	€ 9,686 Retained profit 2023: € 9,686 ▼ 40% vs 2022 (€ 16,167) Unfavourable step	€ 7,554 Retained profit 2024: € 7,554 ▼ 22% vs 2023 (€ 9,686) Unfavourable step	€ 16,642 Retained profit 2025: € 16,642 ▲ 120% vs 2024 (€ 7,554) Favourable step	▲ 120%
Dividend	€ 55,000 Dividend 2022: € 55,000 First fiscal year in the series	€ 35,000 Dividend 2023: € 35,000 ▼ 36% vs 2022 (€ 55,000) Unchanged	€ 20,000 Dividend 2024: € 20,000 ▼ 43% vs 2023 (€ 35,000) Unchanged	€ 20,000 Dividend 2025: € 20,000 Unchanged (€ 20,000) Unchanged
Bank debt	€ 115,723 Bank debt 2022: € 115,723 First fiscal year in the series	€ 94,363 Bank debt 2023: € 94,363 ▼ 18% vs 2022 (€ 115,723) Favourable step	€ 72,395 Bank debt 2024: € 72,395 ▼ 23% vs 2023 (€ 94,363) Favourable step	€ 49,799 Bank debt 2025: € 49,799 ▼ 31% vs 2024 (€ 72,395) Favourable step	▼ 31%
Balance sheet total	€ 383,709 Balance sheet total 2022: € 383,709 First fiscal year in the series	€ 355,109 Balance sheet total 2023: € 355,109 ▼ 7% vs 2022 (€ 383,709) Unchanged	€ 303,461 Balance sheet total 2024: € 303,461 ▼ 15% vs 2023 (€ 355,109) Unchanged	€ 273,800 Balance sheet total 2025: € 273,800 ▼ 10% vs 2024 (€ 303,461) Unchanged	▼ 10%

Key figures of PHARMACIE DEBIEVE SYLVIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DEBIEVE SYLVIE?

What happened at PHARMACIE DEBIEVE SYLVIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 15, 2026 New annual accounts for financial year 2025: profit of € 29,087 (▲ 63% vs 2024). Source: NBB ↗
Mar 13, 2014 New establishment in Honnelles. KBO
Jan 28, 2014 Start of the company according to the CBE. KBO

In short

From € 31,182 profit in 2022 to € 29,087 profit in 2025.

Paid € 43,834 in corporate taxes since 2022.

Best year ever: 2022, with € 31,182 profit.

Paid out € 130,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE DEBIEVE SYLVIE? We notify you, reason included.

Follow PHARMACIE DEBIEVE SYLVIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

SYLVIE DEBIEVE

PHARMACIE DEBIEVE SYLVIE

Behind PHARMACIE DEBIEVE SYLVIE is SYLVIE DEBIEVE.

See the full network in the app

Directors

According to the 2025 annual accounts

SYLVIE DEBIEVE

Administrator-manager

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Charles Bernier(A) 59

7387 Honnelles

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0544.811.683
VAT number: BE 0544.811.683
Registered office: Rue Charles Bernier(A) 59, 7387 Honnelles
Names & denominations: PHARMACIE DEBIEVE SYLVIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 January 2014
Peppol: Active · Active since 3 Apr 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗